Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients-A Comparison between Different Immunomodulating Conditions.
Ofir ZavdyTara CoreanuDvir Yohai Bar-OnAmit RitterGideon BacharThomas ShpitzerNoga KurmanMuhammad MansourDean Ad-ElUri RozovskiGilad ItchakiShany ShermanLimor Azulay-GitterAviram MizrachiPublished in: Cancers (2023)
Among cSCC patients, immunosuppression due to SOTR, CLL, CKD, RA, and psoriasis is associated with worse outcomes compared to controls and other IS groups. These patients should be regarded as high-risk for developing aggressive cSCC tumors. This study is the first to assess and compare cSCC outcomes among multiple IS patient groups.